282 related articles for article (PubMed ID: 20717829)
21. Usefulness of MDCT to Differentiate Between Renal Cell Carcinoma and Oncocytoma: Development of a Predictive Model.
Paño B; Macías N; Salvador R; Torres F; Buñesch L; Sebastià C; Nicolau C
AJR Am J Roentgenol; 2016 Apr; 206(4):764-74. PubMed ID: 26914689
[TBL] [Abstract][Full Text] [Related]
22. Differentiation of Clear Cell Renal Cell Carcinoma from other Renal Cell Carcinoma Subtypes and Benign Oncocytoma Using Quantitative MDCT Enhancement Parameters.
Moldovanu CG; Petresc B; Lebovici A; Tamas-Szora A; Suciu M; Crisan N; Medan P; Buruian MM
Medicina (Kaunas); 2020 Oct; 56(11):. PubMed ID: 33126571
[No Abstract] [Full Text] [Related]
23. Utility of the Aortic-Lesion-Attenuation-Difference (ALAD) and Peak Early-Phase Enhancement Ratio (PEER) to differentiate benign from malignant renal masses.
Kahn AE; Lomax SJ; Bajalia EM; Ball CT; Thiel DD
Can J Urol; 2020 Aug; 27(4):10278-10284. PubMed ID: 32861252
[TBL] [Abstract][Full Text] [Related]
24. Comparison of computed tomography findings between renal oncocytomas and chromophobe renal cell carcinomas.
Choi JH; Kim JW; Lee JY; Han WK; Rha KH; Choi YD; Hong SJ; Yoon YE
Korean J Urol; 2015 Oct; 56(10):695-702. PubMed ID: 26495070
[TBL] [Abstract][Full Text] [Related]
25. Usefulness of rapid kV-switching dual energy CT in renal tumor characterization.
Çamlıdağ İ; Nural MS; Danacı M; Özden E
Abdom Radiol (NY); 2019 May; 44(5):1841-1849. PubMed ID: 30637472
[TBL] [Abstract][Full Text] [Related]
26. Differential radiologic characteristics of renal tumours on multiphasic computed tomography.
Ching BC; Tan HS; Tan PH; Toh CK; Kanesvaran R; Ng QS; Tan MH
Singapore Med J; 2017 May; 58(5):262-266. PubMed ID: 27090599
[TBL] [Abstract][Full Text] [Related]
27. Small renal oncocytomas: differentiation with multiphase CT.
Gakis G; Kramer U; Schilling D; Kruck S; Stenzl A; Schlemmer HP
Eur J Radiol; 2011 Nov; 80(2):274-8. PubMed ID: 20667676
[TBL] [Abstract][Full Text] [Related]
28. Double-phase helical CT of small renal parenchymal neoplasms: correlation with pathologic findings and tumor angiogenesis.
Jinzaki M; Tanimoto A; Mukai M; Ikeda E; Kobayashi S; Yuasa Y; Narimatsu Y; Murai M
J Comput Assist Tomogr; 2000; 24(6):835-42. PubMed ID: 11105696
[TBL] [Abstract][Full Text] [Related]
29. Four-phase computed tomography helps differentiation of renal oncocytoma with central hypodense areas from clear cell renal cell carcinoma.
Qu JY; Jiang H; Song XH; Wu JK; Ma H
Diagn Interv Radiol; 2023 Mar; 29(2):205-211. PubMed ID: 36960636
[TBL] [Abstract][Full Text] [Related]
30. Aorta-Lesion-Attenuation-Difference (ALAD) on contrast-enhanced CT: a potential imaging biomarker for differentiating malignant from benign oncocytic neoplasms.
Dhyani M; Grajo JR; Rodriguez D; Chen Z; Feldman A; Tambouret R; Gervais DA; Arellano RS; Hahn PF; Samir AE
Abdom Radiol (NY); 2017 Jun; 42(6):1734-1743. PubMed ID: 28197683
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic test accuracy of ADC values for identification of clear cell renal cell carcinoma: systematic review and meta-analysis.
Tordjman M; Mali R; Madelin G; Prabhu V; Kang SK
Eur Radiol; 2020 Jul; 30(7):4023-4038. PubMed ID: 32144458
[TBL] [Abstract][Full Text] [Related]
32. CT radiomics for differentiating oncocytoma from renal cell carcinomas: Systematic review and meta-analysis.
Dehghani Firouzabadi F; Gopal N; Homayounieh F; Anari PY; Li X; Ball MW; Jones EC; Samimi S; Turkbey E; Malayeri AA
Clin Imaging; 2023 Feb; 94():9-17. PubMed ID: 36459898
[TBL] [Abstract][Full Text] [Related]
33. The diagnostic utility of diffusion weighted MRI imaging and ADC ratio to distinguish benign from malignant renal masses: sorting the kittens from the tigers.
de Silva S; Lockhart KR; Aslan P; Nash P; Hutton A; Malouf D; Lee D; Cozzi P; MacLean F; Thompson J
BMC Urol; 2021 Apr; 21(1):67. PubMed ID: 33888122
[TBL] [Abstract][Full Text] [Related]
34. Automated classification of solid renal masses on contrast-enhanced computed tomography images using convolutional neural network with decision fusion.
Zabihollahy F; Schieda N; Krishna S; Ukwatta E
Eur Radiol; 2020 Sep; 30(9):5183-5190. PubMed ID: 32350661
[TBL] [Abstract][Full Text] [Related]
35. Renal oncocytoma: CT features cannot reliably distinguish oncocytoma from other renal neoplasms.
Choudhary S; Rajesh A; Mayer NJ; Mulcahy KA; Haroon A
Clin Radiol; 2009 May; 64(5):517-22. PubMed ID: 19348848
[TBL] [Abstract][Full Text] [Related]
36. Messenger RNA expression ratios among four genes predict subtypes of renal cell carcinoma and distinguish oncocytoma from carcinoma.
Chen YT; Tu JJ; Kao J; Zhou XK; Mazumdar M
Clin Cancer Res; 2005 Sep; 11(18):6558-66. PubMed ID: 16166433
[TBL] [Abstract][Full Text] [Related]
37. Preoperative evaluation of renal cell carcinoma by using 18F-FDG PET/CT.
Takahashi M; Kume H; Koyama K; Nakagawa T; Fujimura T; Morikawa T; Fukayama M; Homma Y; Ohtomo K; Momose T
Clin Nucl Med; 2015 Dec; 40(12):936-40. PubMed ID: 26164183
[TBL] [Abstract][Full Text] [Related]
38. Response by authors re: Differentiation of oncocytoma and renal cell carcinoma in small renal masses (<4 cm): the role of 4-phase computerized tomography.
Bird VG; Kanagarajah P; Morillo G; Caruso DJ; Ayyathurai R; Leveillee R; Jorda M
World J Urol; 2013 Aug; 31(4):1011-2. PubMed ID: 21544660
[No Abstract] [Full Text] [Related]
39. Can contrast-enhanced ultrasound and acoustic radiation force impulse imaging characterize CT-indeterminate renal masses? A prospective evaluation with histological confirmation.
Thaiss WM; Bedke J; Kruck S; Spira D; Stenzl A; Nikolaou K; Horger M; Kaufmann S
World J Urol; 2019 Jul; 37(7):1339-1346. PubMed ID: 30324296
[TBL] [Abstract][Full Text] [Related]
40. Can the multiphasic computed tomography be useful in the clinical management of small renal masses?
Gaudiano C; Schiavina R; Vagnoni V; Busato F; Borghesi M; Bandini M; Di Carlo M; Brunocilla E; Martorana G; Golfieri R
Acta Radiol; 2017 May; 58(5):625-633. PubMed ID: 27599523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
